Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' rifampicin mutations. (Record no. 27866157)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02093 a2200541 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517190918.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201811s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1469-0691 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.cmi.2017.11.021 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Abanda, N N |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20181127 |
245 00 - TITLE STATEMENT | |
Title | Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' rifampicin mutations. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases |
Date of publication, distribution, etc. | Jul 2018 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 781.e1-781.e3 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antitubercular Agents |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bacterial Proteins |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Base Sequence |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | DNA, Bacterial |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | DNA-Directed RNA Polymerases |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Diagnosis, Differential |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Diagnostic Tests, Routine |
General subdivision | methods |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Resistance, Bacterial |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genes, Bacterial |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genotype |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Isoniazid |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Microbial Sensitivity Tests |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Microbial Viability |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mutation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mycobacterium tuberculosis |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phenotype |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Rifampin |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tuberculosis, Multidrug-Resistant |
General subdivision | diagnosis |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Djieugoué, J Y |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Khadka, V S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pefura-Yone, E W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mbacham, W F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Vernet, G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Penlap, V M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Deng, Y |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Eyangoh, S I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Taylor, D W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Leke, R G F |
773 0# - HOST ITEM ENTRY | |
Title | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases |
Related parts | vol. 24 |
-- | no. 7 |
-- | p. 781.e1-781.e3 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.cmi.2017.11.021">https://doi.org/10.1016/j.cmi.2017.11.021</a> |
Public note | Available from publisher's website |
No items available.